Deals
![Elektrofi gets $20M from Lilly for drug deal](https://pharmtales.com/wp-content/uploads/2023/10/Elektrofi-lands-20M-from-Eli-Lilly-for-subcutaneous-drug-partnership.jpg)
Elektrofi lands $20M from Eli Lilly for subcutaneous drug partnership
Anika Sharma
Eli Lilly is collaborating with Elektrofi, a drug delivery specialist, to explore the potential of Elektrofi’s microparticle formulation technology in ...
![Merck Ends Some ADC Development with Kelun](https://pharmtales.com/wp-content/uploads/2023/10/Merck-Drops-Two-Cancer-ADCs-from-Kelun-Deal-Focuses-on-Daiichi-Sankyo.jpg)
Merck Drops Two Cancer ADCs from Kelun Deal, Focuses on Daiichi Sankyo
Anika Sharma
Merck & Co. is refining its strategy in the realm of antibody-drug conjugates (ADCs). Shortly after a $4 billion acquisition ...
![Avania buys two medtech CROs, grows globally](https://pharmtales.com/wp-content/uploads/2023/10/Avania-acquires-two-medtech-CROs-broadens-its-global-services-and-expertise.jpg)
Avania acquires two medtech CROs, broadens its global services and expertise
Anika Sharma
Avania, a medtech-focused Contract Research Organization (CRO) headquartered in the Netherlands, has extended its industry expertise through the strategic acquisitions ...
![Vertex and Lonza Partner for New Cell Therapy Manufacturing Facility, Creating Job Opportunities](https://pharmtales.com/wp-content/uploads/2023/06/Vertex-and-Lonza-Partner-for-New-Cell-Therapy-Manufacturing-Facility-Creating-Job-Opportunities.jpg)
Vertex and Lonza Partner for New Cell Therapy Manufacturing Facility, Creating Job Opportunities
SG Tylor
Source – Vertex Pharmaceuticals With promising developments in its experimental cell therapy VX-880 for type I diabetes, Vertex Pharmaceuticals is ...